Date |
Manual Section |
Edit Type |
Description |
4/30/18 |
2450: Post-TED |
Add |
Added the following instruction for question 34.Please note, questions 35 and 36 must still be answered if question 34 is reported as "unknown." |
4/30/18 |
2450: Post-TED |
Modify |
Updated language on how to report the "Date of most recent disease assessment" for questions 237-238: current disease status. |
4/23/18 |
2018: LYM Pre-Infusion Data |
Modify |
Corrected errors in the instruction manual by adding (in red below) and removing (struck out below) text to the instructions for questions 269-272, 273-276, and 277-280. Indicate the result of [method] testing performed at the last evaluation prior to the start of the preparative regimen / infusion. If testing was "Positive," or "Negative," report the sample source in questions [question numbers]... If all [method] testing was negative or testing was not done at the last evaluation prior to the start of the preparative regimen, report "Negative" or "Not done" respectively... |
4/20/18 |
Appendix M: Critical Data Fields |
Modify |
New version of Appendix M: Critical Data Fields of the Forms Instructions Manual released. Note, prior versions of this appendix were referred to as Appendix Y: Critical Data Fields. |
4/20/18 |
4003: Cellular Therapy Product |
Add |
Added Cryopreservation as a Manipulation note box to the instructions for questions 31-32. |
4/16/18 |
2000: Recipient Baseline |
Add |
Added Fungal Infection Diagnosis Reporting Scenario to the instructions for question 57. |
4/10/18 |
2402: Disease Classification |
Modify |
Updated the Common Disease Transformation Table included in the instructions for questions 1 and 2. The CLL section of the form should not be completed for a Richter's Transformation as of Revision 3 of the Form 2402. |
4/10/18 |
4006: Cellular Therapy Infusion |
Add |
Added in additional clarification regarding total cell counts administered, what constitutes unselected lymphocytes, and T-helper cells (Q17-24). |
4/9/18 |
2402: Disease Classification |
Modify |
Modified the following instruction for question 317: Enter the date of the most recent assessment of disease status prior to the start of the preparative regimen. Report the date the blood/urine was collected for the laboratory evaluations (e.g., SPEP/UPEP, serum/urine immunofixation) or report the date the bone marrow was collected for pathological evaluation. A PET scan Date of radiographic study (PET, MRI, CT) may be used if the same a previous PET scan radiographic study had previously been obtained and only in limited circumstances (e.g., plasmacytomas, lytic lesions). |